Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gossamer Bio Inc (NQ: GOSS ) 1.070 +0.060 (+5.94%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Gossamer Bio Inc < Previous 1 2 3 4 5 6 Next > 12 Health Care Stocks Moving In Monday's Pre-Market Session April 25, 2022 Via Benzinga Gossamer Bio Announces GB004 Topline Results from Phase 2 SHIFT-UC Study in Ulcerative Colitis and Provides Corporate Update April 25, 2022 From Gossamer Bio, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2022 April 18, 2022 Upgrades Via Benzinga Recap: Gossamer Bio Q4 Earnings March 03, 2022 Gossamer Bio (NASDAQ:GOSS) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings... Via Benzinga Gossamer Bio Earnings Preview March 02, 2022 Gossamer Bio (NASDAQ:GOSS) is set to give its latest quarterly earnings report on Thursday, 2022-03-03. Here's what investors need to know before the announcement. Analysts... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session April 06, 2022 Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 32.4% to $7.43 during Wednesday's regular session. Sunshine Biopharma's stock is trading at a volume of 46.8... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022 April 06, 2022 Upgrades Via Benzinga The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight August 08, 2021 Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... Via Benzinga Exposures Product Safety Earnings Scheduled For March 3, 2022 March 03, 2022 Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban... Via Benzinga Gossamer Bio to Announce Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call and Webcast on March 3, 2022 February 28, 2022 From Gossamer Bio, Inc. Via Business Wire Gossamer Bio Announces Third Quarter 2021 Financial Results and Provides Corporate Update November 08, 2021 From Gossamer Bio, Inc. Via Business Wire Gossamer Bio to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 8, 2021 November 02, 2021 From Gossamer Bio, Inc. Via Business Wire Gossamer Bio Announces Addition of Two CNS-Penetrant BTK Inhibitors to its Product Candidate Pipeline: GB5121 & GB7208 October 11, 2021 From Gossamer Bio, Inc. Via Business Wire Gossamer Bio to Host Webcast Announcing its Next Clinical Product Candidates on October 11, 2021 October 07, 2021 From Gossamer Bio, Inc. Via Business Wire 12 Health Care Stocks Moving In Monday's Intraday Session September 27, 2021 Gainers Keros Therapeutics (NASDAQ:KROS) stock moved upwards by 26.51% to $41.75 during Monday's regular session. Keros Therapeutics's stock is trading at a volume... Via Benzinga The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive September 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 27) Acceleron Pharma Inc. (... Via Benzinga 31 Stocks Moving In Monday's Mid-Day Session September 27, 2021 Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 54.1% to $3.6998 after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from NASA to... Via Benzinga 50 Biggest Movers From Yesterday September 28, 2021 Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 50% to close at $3.60 on Monday after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from... Via Benzinga Gossamer Bio Announces Appointment of Bryan Giraudo as Chief Operating Officer, in addition to Chief Financial Officer Role September 21, 2021 From Gossamer Bio, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's After-Market Session August 20, 2021 Gainers CASI Pharmaceuticals (NASDAQ:CASI Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session August 16, 2021 Gainers ADMA Biologics (NASDAQ:ADMA) stock rose 18.79% to $1.77 during Monday's pre-market session. The company's market cap stands at $226.8 million. The company... Via Benzinga Gossamer Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update August 09, 2021 From Gossamer Bio, Inc. Via Business Wire Gossamer Bio to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 9, 2021 August 02, 2021 From Gossamer Bio, Inc. Via Business Wire The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street July 20, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated... Via Benzinga The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study July 16, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:... Via Benzinga Topics Stocks Exposures US Equities The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs July 15, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,... Via Benzinga Topics Product Recall Exposures Legal Product Safety Gossamer Bio Announces GB004 Clinical Trial Data Presentations at 2021 Virtual Congress of the European Crohn’s and Colitis Organisation July 07, 2021 From Gossamer Bio, Inc. Via Business Wire The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal June 22, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc... Via Benzinga Gossamer Bio Announces Promotion of Richard Aranda, M.D., to Chief Medical Officer June 21, 2021 From Gossamer Bio, Inc. Via Business Wire Gossamer Bio Announces Appointment of Sandra Milligan, M.D., J.D., to its Board of Directors June 14, 2021 From Gossamer Bio Via Business Wire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.